Browsing by Subject "Gamma knife"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Ion chamber measurements of transverse gamma knife beam profiles
    (American Association of Physicists in Medicine, 2002) Bank, Morris I.; Radiation Oncology, School of Medicine
    A microchamber, PTW Pinpoint 31006, was used to measure transverse beam profiles for an Elekta Gamma Knife, Model B, and compared with profiles measured with film dosimetry. The microchamber sensitive volume has a diameter of 2 mm, which is smaller than the gamma knife beams, and a length of 5 mm. The chamber was mounted in a custom cassette in a spherical plastic phantom, supplied by Elekta, and oriented in a sagittal plane with the 2-mm dimension at right angles to the transverse plane. The phantom was manually moved across the beam, using the gamma knife x-coordinate trunnions, to measure the profiles. Profiles were also measured with V-film placed in a cassette mounted in the spherical plastic phantom. The films were scanned with a Scanditronix film scanner and converted to dose with a density to dose calibration curve. The results were superimposed for comparison. The beam width at the 50% intensity was measured from the film profiles to give the dimensions of the beams in the orthagonal planes. The ion chamber measurements are compared with the film results for the transverse, x profiles. Good agreement between the film and ion chamber transverse profiles is observed.
  • Thumbnail Image
    Item
    Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol
    (Elsevier, 2020) McClelland, Shearwood, III.; Lautenschlaeger, Tim; Zang, Yong; Hanna, Nasser H.; Shiue, Kevin; Kamer, Aaron P.; Agrawal, Namita; Ellsworth, Susannah G.; Rhome, Ryan M.; Watson, Gordon A.; Radiation Oncology, School of Medicine
    Introduction: Up to 20% of patients with brain metastases treated with immune checkpoint inhibitor (ICI) therapy and concomitant stereotactic radiosurgery (SRS) suffer from symptomatic radiation necrosis. The goal of this study is to evaluate Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI) on six-month symptomatic radiation necrosis rates. Methods: This study is a prospective single arm Phase I pilot study which will recruit patients with brain metastases receiving ICI delivered within 30 days before SRS. All patients will be treated with RADREMI dosing, which involves SRS doses of 18 Gy for 0-2 cm lesions, 14 Gy for 2.1-3 cm lesions, and 12 Gy for 3.1-4 cm lesions. All patients will be monitored for six-month symptomatic radiation necrosis (defined as a six-month rate of clinical symptomatology requiring steroid administration and/or operative intervention concomitant with imaging findings consistent with radiation necrosis) and six-month local control. We expect that RADREMI dosing will significantly reduce the symptomatic radiation necrosis rate of concomitant SRS + ICI without significantly sacrificing the local control obtained by the present RTOG 90-05 SRS dosing schema. Local control will be defined according to the Response Assessment in Neuro-Oncology (RANO) criteria. Discussion: This study is the first prospective trial to investigate the safety of dose-reduced SRS in treatment of brain metastases with concomitant ICI. The findings should provide fertile soil for future multi-institutional collaborative efficacy trials of RADREMI dosing for this patient population.
  • Thumbnail Image
    Item
    Superimposition of beams to vary shot size in gamma knife stereotactic radiosurgery
    (American Association of Physicists in Medicine, 2002) Bank, Morris I.; Timmerman, Robert; Radiation Oncology, School of Medicine
    The Leksell Gamma Knife [Elekta Corp] uses helmets as collimators to produce four standard beam sizes. The nominal beam diameters are 18, 14, 8, and 4 mm. During computer treatment planning for gamma knife stereotactic radiosurgery, the size of the treated volume may differ from the standard beam sizes. To maintain conformality of the isodose curves to the treated volume, beam sizes may be superimposed during computer treatment planning to produce beam diameters that are intermediate to the standard beams. A study of superimposed gamma knife beams was performed to confirm the accuracy of this method and to verify the accuracy of the GammaPlan treatment planning computer. Superimposed beams were simulated on the Elekta treatment planning computer, GammaPlan, version 4.12, and tested by film measurements of beam profiles for single helmet sizes and superimposed shots with various beam weightings. The weighting for each beam size is varied to attain the beam size diameter desired. The beams were defined at the 50% isodose line. The profiles of the superimposed beams were obtained and compared with the single helmet shots. The uniformity of the resulting beams was measured. The results show a linear relationship between beam size and beam weighting for the superimposed beams. The film measurements confirm the computer calculations.